Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ocuphire Pharma, Inc. | Chief Scientific & Dev. Ofc. | Common Stock | 78.5K | $139K | $1.77 | May 22, 2024 | Direct |
Ocuphire Pharma, Inc. | Chief Scientific & Dev. Ofc. | Employee Stock Option (right to buy) | 225K | Feb 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OCUP | Ocuphire Pharma, Inc. | May 22, 2024 | 1 | $6.18K | 4 | May 24, 2024 | Chief Scientific & Dev. Ofc. |
OCUP | Ocuphire Pharma, Inc. | Feb 12, 2024 | 2 | $0 | 4 | Feb 14, 2024 | Chief Scientific & Dev. Ofc. |
OCUP | Ocuphire Pharma, Inc. | Feb 12, 2024 | 0 | $0 | 3 | Feb 14, 2024 | Chief Scientific & Dev. Ofc. |